Article Text

Download PDFPDF

Cardiac markers in Black, Asian and minority ethnic (BAME) patients with COVID-19
  1. Ruvini N K Ranasinghe,
  2. David R Taylor,
  3. Tina Mazaheri,
  4. Wiaam Al-Hasani,
  5. Devon Buchanan,
  6. Nandini Rao,
  7. Royce P Vincent
  1. Department of Clinical Biochemistry, King's College Hospital NHS Foundation Trust, London, UK
  1. Correspondence to Dr Ruvini N K Ranasinghe, Department of Clinical Biochemistry, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK; ruvini.ranasinghe{at}

Statistics from

The novel coronavirus, SARS-CoV-2, which causes COVID-19, has rapidly progressed to a global health emergency.1 COVID-19 predominantly presents with respiratory complications and associated mortality; however, emerging reports show that patients can present with cardiac involvement.1 Cardiovascular manifestations are not unique to COVID-19 as cardiac involvement have been reported with SARS-CoV and Middle East respiratory syndrome-CoV in the past.2 The pandemic in the UK has highlighted the higher risk to the Black, Asian and minority ethnic (BAME) population of adverse clinical outcomes compared with patients of white British ethnicity.3 Furthermore, BAME men aged over 50 years are noted to be at an even higher risk of severe COVID-19.4

We retrospectively reviewed the cardiac markers Troponin T, N-terminal pro B-type natriuretic peptide (NT-proBNP) and the inflammation marker C reactive protein (CRP) requested in patients with suspected COVID-19, admitted to a tertiary London hospital during the peak of the pandemic (April 2020) in the UK. Only patients who had a Troponin measurement (with or without …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.